Literature DB >> 11872879

Prevalence of different HIV-1 subtypes in an urban clinic in Madrid.

J C Martín1, A Holguín, V Soriano.   

Abstract

The introduction of non-B HIV-1 variants into Western Europe and North America is of great concern since diagnostic tools and drugs are mainly optimised for targeting HIV-1 subtype B viruses. Madrid is an endemic area for HIV, and either the final destination or transient location for many immigrants from HIV-1 non-B endemic areas (mainly from Africa and South America). From a total of 902 HIV seropositive individuals examined since June 1999, only 27 (3%) were found to be infected with non-B HIV variants. However, up to 71.4% of African immigrants carried non-B viruses. Therefore, HIV subtyping should be requested from all HIV infected African immigrants before considering viral load testing and recommending antiretroviral therapy.

Entities:  

Mesh:

Year:  2002        PMID: 11872879      PMCID: PMC1763697          DOI: 10.1136/sti.78.1.e1

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  6 in total

1.  Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naïve patients with undetectable viraemia. The Master Group.

Authors:  M Clerici; E Seminari; F Suter; F Castelli; A Pan; M Biasin; F Colombo; D Trabattoni; F Maggiolo; G Carosi; R Maserati
Journal:  AIDS       Date:  2000-01-28       Impact factor: 4.177

2.  Prevalence of human immunodeficiency virus type 1 (HIV-1) non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances of the AMPLICOR HIV-1 MONITOR version 1.0 and the new automated version 1.5.

Authors:  A Holguín; B Aracil; A Alvarez; C Barros; V Soriano
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  Drug susceptibility of subtypes A,B,C,D, and E human immunodeficiency virus type 1 primary isolates.

Authors:  S Palmer; A Alaeus; J Albert; S Cox
Journal:  AIDS Res Hum Retroviruses       Date:  1998-01-20       Impact factor: 2.205

4.  Protease sequences from HIV-1 group M subtypes A-H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide. HIV Variant Working Group.

Authors:  D Pieniazek; M Rayfield; D J Hu; J Nkengasong; S Z Wiktor; R Downing; B Biryahwaho; T Mastro; A Tanuri; V Soriano; R Lal; T Dondero
Journal:  AIDS       Date:  2000-07-28       Impact factor: 4.177

5.  Protease gene analysis of HIV type 1 non-B subtypes in Spain.

Authors:  A Holguín; B Rodés; V Soriano
Journal:  AIDS Res Hum Retroviruses       Date:  2000-09-20       Impact factor: 2.205

6.  HIV-1 diversity in France, 1996-1998. The AC 11 laboratory network.

Authors:  E Couturier; F Damond; P Roques; H Fleury; F Barin; J B Brunet; F Brun-Vézinet; F Simon
Journal:  AIDS       Date:  2000-02-18       Impact factor: 4.177

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.